Intercontinental dissemination of azithromycin-resistant shigellosis through sexual transmission: a cross-sectional study

Summary Background Shigellosis is an acute, severe bacterial colitis that, in high-income countries, is typically associated with travel to high-risk regions (Africa, Asia, and Latin America). Since the 1970s, shigellosis has also been reported as a sexually transmitted infection in men who have sex...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet infectious diseases 2015-08, Vol.15 (8), p.913-921
Hauptverfasser: Baker, Kate S, PhD, Dallman, Timothy J, PhD, Ashton, Philip M, PhD, Day, Martin, BSc, Hughes, Gwenda, PhD, Crook, Paul D, MSc, Gilbart, Victoria L, MSc, Zittermann, Sandra, PhD, Allen, Vanessa G, MD, Howden, Benjamin P, Prof, Tomita, Takehiro, PhD, Valcanis, Mary, MPH, Harris, Simon R, PhD, Connor, Thomas R, PhD, Sintchenko, Vitali, PhD, Howard, Peter, BSc, Brown, Jeremy D, MBBS, Petty, Nicola K, PhD, Gouali, Malika, PharmD, Thanh, Duy Pham, MSc, Keddy, Karen H, BSc (Med), Smith, Anthony M, PhD, Talukder, Kaisar A, PhD, Faruque, Shah M, PhD, Parkhill, Julian, Prof, Baker, Stephen, Prof, Weill, François-Xavier, PhD, Jenkins, Claire, PhD, Thomson, Nicholas R, Prof
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 921
container_issue 8
container_start_page 913
container_title The Lancet infectious diseases
container_volume 15
creator Baker, Kate S, PhD
Dallman, Timothy J, PhD
Ashton, Philip M, PhD
Day, Martin, BSc
Hughes, Gwenda, PhD
Crook, Paul D, MSc
Gilbart, Victoria L, MSc
Zittermann, Sandra, PhD
Allen, Vanessa G, MD
Howden, Benjamin P, Prof
Tomita, Takehiro, PhD
Valcanis, Mary, MPH
Harris, Simon R, PhD
Connor, Thomas R, PhD
Sintchenko, Vitali, PhD
Howard, Peter, BSc
Brown, Jeremy D, MBBS
Petty, Nicola K, PhD
Gouali, Malika, PharmD
Thanh, Duy Pham, MSc
Keddy, Karen H, BSc (Med)
Smith, Anthony M, PhD
Talukder, Kaisar A, PhD
Faruque, Shah M, PhD
Parkhill, Julian, Prof
Baker, Stephen, Prof
Weill, François-Xavier, PhD
Jenkins, Claire, PhD
Thomson, Nicholas R, Prof
description Summary Background Shigellosis is an acute, severe bacterial colitis that, in high-income countries, is typically associated with travel to high-risk regions (Africa, Asia, and Latin America). Since the 1970s, shigellosis has also been reported as a sexually transmitted infection in men who have sex with men (MSM), in whom transmission is an important component of shigellosis epidemiology in high-income nations. We aimed to use sophisticated subtyping and international sampling to determine factors driving shigellosis emergence in MSM linked to an outbreak in the UK. Methods We did a large-scale, cross-sectional genomic epidemiological study of shigellosis cases collected from 29 countries between December, 1995, and June 8, 2014. Focusing on an ongoing epidemic in the UK, we collected and whole-genome sequenced clinical isolates of Shigella flexneri serotype 3a from high-risk and low-risk regions, including cases associated with travel and sex between men. We examined relationships between geographical, demographic, and clinical patient data with the isolate antimicrobial susceptibility, genetic data, and inferred evolutionary relationships. Findings We obtained 331 clinical isolates of S flexneri serotype 3a, including 275 from low-risk regions (44 from individuals who travelled to high-risk regions), 52 from high-risk regions, and four outgroup samples (ie, closely related, but genetically distinct isolates used to determine the root of the phylogenetic tree). We identified a recently emerged lineage of S flexneri 3a that has spread intercontinentally in less than 20 years throughout regions traditionally at low risk for shigellosis via sexual transmission in MSM. The lineage had acquired multiple antimicrobial resistance determinants, and prevailing sublineages were strongly associated with resistance to the macrolide azithromycin. Eight (4%) of 206 isolates from the MSM-associated lineage were obtained from patients who had previously provided an isolate; these serial isolations indicated atypical infection patterns (eg, reinfection). Interpretation We identified transmission-facilitating behaviours and atypical course(s) of infection as precipitating factors in shigellosis-affected MSM. The intercontinental spread of antimicrobial-resistant shigella through established transmission routes emphasises the need for new approaches to tackle the public health challenge of sexually transmitted infections in MSM. Funding Wellcome Trust (grant number 098051)
doi_str_mv 10.1016/S1473-3099(15)00002-X
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_pasteur_02042957v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S147330991500002X</els_id><sourcerecordid>3773071011</sourcerecordid><originalsourceid>FETCH-LOGICAL-c655t-292ecc93f31e0299f0b0a1aa7624ebc26d6daf3df4831cc5c9ecfe9af8ddd52c3</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhiMEoh_wE0CRuJRDwB9xUnMAVRXQSitxAKS9WV570nXJ2luPU5H-epykFKkXfIkdP_MkM29RvKLkHSW0ef-d1i2vOJHyhIq3JC9WrZ8Uh_l1XdW1aJ_O-wU5KI4QrwmhLSX18-KACcmbhtLDYrz0CaIJPjkPPum-tA4Rds7r5IIvQ1fqO5e2MexG43wVAR0m7VOJW3cFfR_yuZzuh6ttifB7yIoUtcdd9mTDh1KXJgbECsFMynyPabDji-JZp3uEl_fP4-Lnl88_zi-q1bevl-dnq8o0QqSKSQbGSN5xCoRJ2ZEN0VTrtmE1bAxrbGN1x21Xn3JqjDASTAdSd6fWWsEMPy6qxbvVvdpHt9NxVEE7dXG2UnuNCYaoCCM1k6K9pZk_Wfh9DDcDYFK5E5M71R7CgIq2hHJKZDuhbx6h12GIucOZYi2pWyIyJRZqHkOE7uEvKFFTlmrOUk1BKSrUnKVa57rX9_ZhswP7UPU3vAx8WgDI47t1EBUaB96AdTHPWtng_vuJj48MpnfeGd3_ghHwXzcKmSKLZHJQMRvW_A-uGMdB</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1702704705</pqid></control><display><type>article</type><title>Intercontinental dissemination of azithromycin-resistant shigellosis through sexual transmission: a cross-sectional study</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Baker, Kate S, PhD ; Dallman, Timothy J, PhD ; Ashton, Philip M, PhD ; Day, Martin, BSc ; Hughes, Gwenda, PhD ; Crook, Paul D, MSc ; Gilbart, Victoria L, MSc ; Zittermann, Sandra, PhD ; Allen, Vanessa G, MD ; Howden, Benjamin P, Prof ; Tomita, Takehiro, PhD ; Valcanis, Mary, MPH ; Harris, Simon R, PhD ; Connor, Thomas R, PhD ; Sintchenko, Vitali, PhD ; Howard, Peter, BSc ; Brown, Jeremy D, MBBS ; Petty, Nicola K, PhD ; Gouali, Malika, PharmD ; Thanh, Duy Pham, MSc ; Keddy, Karen H, BSc (Med) ; Smith, Anthony M, PhD ; Talukder, Kaisar A, PhD ; Faruque, Shah M, PhD ; Parkhill, Julian, Prof ; Baker, Stephen, Prof ; Weill, François-Xavier, PhD ; Jenkins, Claire, PhD ; Thomson, Nicholas R, Prof</creator><creatorcontrib>Baker, Kate S, PhD ; Dallman, Timothy J, PhD ; Ashton, Philip M, PhD ; Day, Martin, BSc ; Hughes, Gwenda, PhD ; Crook, Paul D, MSc ; Gilbart, Victoria L, MSc ; Zittermann, Sandra, PhD ; Allen, Vanessa G, MD ; Howden, Benjamin P, Prof ; Tomita, Takehiro, PhD ; Valcanis, Mary, MPH ; Harris, Simon R, PhD ; Connor, Thomas R, PhD ; Sintchenko, Vitali, PhD ; Howard, Peter, BSc ; Brown, Jeremy D, MBBS ; Petty, Nicola K, PhD ; Gouali, Malika, PharmD ; Thanh, Duy Pham, MSc ; Keddy, Karen H, BSc (Med) ; Smith, Anthony M, PhD ; Talukder, Kaisar A, PhD ; Faruque, Shah M, PhD ; Parkhill, Julian, Prof ; Baker, Stephen, Prof ; Weill, François-Xavier, PhD ; Jenkins, Claire, PhD ; Thomson, Nicholas R, Prof</creatorcontrib><description>Summary Background Shigellosis is an acute, severe bacterial colitis that, in high-income countries, is typically associated with travel to high-risk regions (Africa, Asia, and Latin America). Since the 1970s, shigellosis has also been reported as a sexually transmitted infection in men who have sex with men (MSM), in whom transmission is an important component of shigellosis epidemiology in high-income nations. We aimed to use sophisticated subtyping and international sampling to determine factors driving shigellosis emergence in MSM linked to an outbreak in the UK. Methods We did a large-scale, cross-sectional genomic epidemiological study of shigellosis cases collected from 29 countries between December, 1995, and June 8, 2014. Focusing on an ongoing epidemic in the UK, we collected and whole-genome sequenced clinical isolates of Shigella flexneri serotype 3a from high-risk and low-risk regions, including cases associated with travel and sex between men. We examined relationships between geographical, demographic, and clinical patient data with the isolate antimicrobial susceptibility, genetic data, and inferred evolutionary relationships. Findings We obtained 331 clinical isolates of S flexneri serotype 3a, including 275 from low-risk regions (44 from individuals who travelled to high-risk regions), 52 from high-risk regions, and four outgroup samples (ie, closely related, but genetically distinct isolates used to determine the root of the phylogenetic tree). We identified a recently emerged lineage of S flexneri 3a that has spread intercontinentally in less than 20 years throughout regions traditionally at low risk for shigellosis via sexual transmission in MSM. The lineage had acquired multiple antimicrobial resistance determinants, and prevailing sublineages were strongly associated with resistance to the macrolide azithromycin. Eight (4%) of 206 isolates from the MSM-associated lineage were obtained from patients who had previously provided an isolate; these serial isolations indicated atypical infection patterns (eg, reinfection). Interpretation We identified transmission-facilitating behaviours and atypical course(s) of infection as precipitating factors in shigellosis-affected MSM. The intercontinental spread of antimicrobial-resistant shigella through established transmission routes emphasises the need for new approaches to tackle the public health challenge of sexually transmitted infections in MSM. Funding Wellcome Trust (grant number 098051).</description><identifier>ISSN: 1473-3099</identifier><identifier>EISSN: 1474-4457</identifier><identifier>DOI: 10.1016/S1473-3099(15)00002-X</identifier><identifier>PMID: 25936611</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Adolescent ; Adult ; Aged ; Antibiotics ; Azithromycin - therapeutic use ; Bacteriology ; Child ; Child, Preschool ; Criminal investigations ; Cross-Sectional Studies ; Disease ; Disease Outbreaks ; Drug Resistance, Bacterial - drug effects ; Dysentery, Bacillary - drug therapy ; Dysentery, Bacillary - epidemiology ; Epidemiology ; Evidence ; Female ; Genomes ; Humans ; Infant ; Infant, Newborn ; Infections ; Infectious Disease ; Infectious diseases ; Life Sciences ; Male ; Medical research ; Men ; Mens health ; Microbiology and Parasitology ; Middle Aged ; Phylogeny ; Public health ; Risk ; Santé publique et épidémiologie ; Sexually transmitted diseases ; Sexually Transmitted Diseases - drug therapy ; Sexually Transmitted Diseases - epidemiology ; Sexually Transmitted Diseases - microbiology ; Shigella flexneri - drug effects ; Shigellosis ; STD ; Studies ; Travel ; United Kingdom - epidemiology ; Young Adult</subject><ispartof>The Lancet infectious diseases, 2015-08, Vol.15 (8), p.913-921</ispartof><rights>Elsevier Ltd</rights><rights>2015 Elsevier Ltd</rights><rights>Copyright © 2015 Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Limited Aug 2015</rights><rights>Attribution</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c655t-292ecc93f31e0299f0b0a1aa7624ebc26d6daf3df4831cc5c9ecfe9af8ddd52c3</citedby><cites>FETCH-LOGICAL-c655t-292ecc93f31e0299f0b0a1aa7624ebc26d6daf3df4831cc5c9ecfe9af8ddd52c3</cites><orcidid>0000-0001-9941-5799 ; 0000-0002-7898-7664</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S147330991500002X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25936611$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://pasteur.hal.science/pasteur-02042957$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Baker, Kate S, PhD</creatorcontrib><creatorcontrib>Dallman, Timothy J, PhD</creatorcontrib><creatorcontrib>Ashton, Philip M, PhD</creatorcontrib><creatorcontrib>Day, Martin, BSc</creatorcontrib><creatorcontrib>Hughes, Gwenda, PhD</creatorcontrib><creatorcontrib>Crook, Paul D, MSc</creatorcontrib><creatorcontrib>Gilbart, Victoria L, MSc</creatorcontrib><creatorcontrib>Zittermann, Sandra, PhD</creatorcontrib><creatorcontrib>Allen, Vanessa G, MD</creatorcontrib><creatorcontrib>Howden, Benjamin P, Prof</creatorcontrib><creatorcontrib>Tomita, Takehiro, PhD</creatorcontrib><creatorcontrib>Valcanis, Mary, MPH</creatorcontrib><creatorcontrib>Harris, Simon R, PhD</creatorcontrib><creatorcontrib>Connor, Thomas R, PhD</creatorcontrib><creatorcontrib>Sintchenko, Vitali, PhD</creatorcontrib><creatorcontrib>Howard, Peter, BSc</creatorcontrib><creatorcontrib>Brown, Jeremy D, MBBS</creatorcontrib><creatorcontrib>Petty, Nicola K, PhD</creatorcontrib><creatorcontrib>Gouali, Malika, PharmD</creatorcontrib><creatorcontrib>Thanh, Duy Pham, MSc</creatorcontrib><creatorcontrib>Keddy, Karen H, BSc (Med)</creatorcontrib><creatorcontrib>Smith, Anthony M, PhD</creatorcontrib><creatorcontrib>Talukder, Kaisar A, PhD</creatorcontrib><creatorcontrib>Faruque, Shah M, PhD</creatorcontrib><creatorcontrib>Parkhill, Julian, Prof</creatorcontrib><creatorcontrib>Baker, Stephen, Prof</creatorcontrib><creatorcontrib>Weill, François-Xavier, PhD</creatorcontrib><creatorcontrib>Jenkins, Claire, PhD</creatorcontrib><creatorcontrib>Thomson, Nicholas R, Prof</creatorcontrib><title>Intercontinental dissemination of azithromycin-resistant shigellosis through sexual transmission: a cross-sectional study</title><title>The Lancet infectious diseases</title><addtitle>Lancet Infect Dis</addtitle><description>Summary Background Shigellosis is an acute, severe bacterial colitis that, in high-income countries, is typically associated with travel to high-risk regions (Africa, Asia, and Latin America). Since the 1970s, shigellosis has also been reported as a sexually transmitted infection in men who have sex with men (MSM), in whom transmission is an important component of shigellosis epidemiology in high-income nations. We aimed to use sophisticated subtyping and international sampling to determine factors driving shigellosis emergence in MSM linked to an outbreak in the UK. Methods We did a large-scale, cross-sectional genomic epidemiological study of shigellosis cases collected from 29 countries between December, 1995, and June 8, 2014. Focusing on an ongoing epidemic in the UK, we collected and whole-genome sequenced clinical isolates of Shigella flexneri serotype 3a from high-risk and low-risk regions, including cases associated with travel and sex between men. We examined relationships between geographical, demographic, and clinical patient data with the isolate antimicrobial susceptibility, genetic data, and inferred evolutionary relationships. Findings We obtained 331 clinical isolates of S flexneri serotype 3a, including 275 from low-risk regions (44 from individuals who travelled to high-risk regions), 52 from high-risk regions, and four outgroup samples (ie, closely related, but genetically distinct isolates used to determine the root of the phylogenetic tree). We identified a recently emerged lineage of S flexneri 3a that has spread intercontinentally in less than 20 years throughout regions traditionally at low risk for shigellosis via sexual transmission in MSM. The lineage had acquired multiple antimicrobial resistance determinants, and prevailing sublineages were strongly associated with resistance to the macrolide azithromycin. Eight (4%) of 206 isolates from the MSM-associated lineage were obtained from patients who had previously provided an isolate; these serial isolations indicated atypical infection patterns (eg, reinfection). Interpretation We identified transmission-facilitating behaviours and atypical course(s) of infection as precipitating factors in shigellosis-affected MSM. The intercontinental spread of antimicrobial-resistant shigella through established transmission routes emphasises the need for new approaches to tackle the public health challenge of sexually transmitted infections in MSM. Funding Wellcome Trust (grant number 098051).</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Antibiotics</subject><subject>Azithromycin - therapeutic use</subject><subject>Bacteriology</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Criminal investigations</subject><subject>Cross-Sectional Studies</subject><subject>Disease</subject><subject>Disease Outbreaks</subject><subject>Drug Resistance, Bacterial - drug effects</subject><subject>Dysentery, Bacillary - drug therapy</subject><subject>Dysentery, Bacillary - epidemiology</subject><subject>Epidemiology</subject><subject>Evidence</subject><subject>Female</subject><subject>Genomes</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Infections</subject><subject>Infectious Disease</subject><subject>Infectious diseases</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Medical research</subject><subject>Men</subject><subject>Mens health</subject><subject>Microbiology and Parasitology</subject><subject>Middle Aged</subject><subject>Phylogeny</subject><subject>Public health</subject><subject>Risk</subject><subject>Santé publique et épidémiologie</subject><subject>Sexually transmitted diseases</subject><subject>Sexually Transmitted Diseases - drug therapy</subject><subject>Sexually Transmitted Diseases - epidemiology</subject><subject>Sexually Transmitted Diseases - microbiology</subject><subject>Shigella flexneri - drug effects</subject><subject>Shigellosis</subject><subject>STD</subject><subject>Studies</subject><subject>Travel</subject><subject>United Kingdom - epidemiology</subject><subject>Young Adult</subject><issn>1473-3099</issn><issn>1474-4457</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkU1v1DAQhiMEoh_wE0CRuJRDwB9xUnMAVRXQSitxAKS9WV570nXJ2luPU5H-epykFKkXfIkdP_MkM29RvKLkHSW0ef-d1i2vOJHyhIq3JC9WrZ8Uh_l1XdW1aJ_O-wU5KI4QrwmhLSX18-KACcmbhtLDYrz0CaIJPjkPPum-tA4Rds7r5IIvQ1fqO5e2MexG43wVAR0m7VOJW3cFfR_yuZzuh6ttifB7yIoUtcdd9mTDh1KXJgbECsFMynyPabDji-JZp3uEl_fP4-Lnl88_zi-q1bevl-dnq8o0QqSKSQbGSN5xCoRJ2ZEN0VTrtmE1bAxrbGN1x21Xn3JqjDASTAdSd6fWWsEMPy6qxbvVvdpHt9NxVEE7dXG2UnuNCYaoCCM1k6K9pZk_Wfh9DDcDYFK5E5M71R7CgIq2hHJKZDuhbx6h12GIucOZYi2pWyIyJRZqHkOE7uEvKFFTlmrOUk1BKSrUnKVa57rX9_ZhswP7UPU3vAx8WgDI47t1EBUaB96AdTHPWtng_vuJj48MpnfeGd3_ghHwXzcKmSKLZHJQMRvW_A-uGMdB</recordid><startdate>20150801</startdate><enddate>20150801</enddate><creator>Baker, Kate S, PhD</creator><creator>Dallman, Timothy J, PhD</creator><creator>Ashton, Philip M, PhD</creator><creator>Day, Martin, BSc</creator><creator>Hughes, Gwenda, PhD</creator><creator>Crook, Paul D, MSc</creator><creator>Gilbart, Victoria L, MSc</creator><creator>Zittermann, Sandra, PhD</creator><creator>Allen, Vanessa G, MD</creator><creator>Howden, Benjamin P, Prof</creator><creator>Tomita, Takehiro, PhD</creator><creator>Valcanis, Mary, MPH</creator><creator>Harris, Simon R, PhD</creator><creator>Connor, Thomas R, PhD</creator><creator>Sintchenko, Vitali, PhD</creator><creator>Howard, Peter, BSc</creator><creator>Brown, Jeremy D, MBBS</creator><creator>Petty, Nicola K, PhD</creator><creator>Gouali, Malika, PharmD</creator><creator>Thanh, Duy Pham, MSc</creator><creator>Keddy, Karen H, BSc (Med)</creator><creator>Smith, Anthony M, PhD</creator><creator>Talukder, Kaisar A, PhD</creator><creator>Faruque, Shah M, PhD</creator><creator>Parkhill, Julian, Prof</creator><creator>Baker, Stephen, Prof</creator><creator>Weill, François-Xavier, PhD</creator><creator>Jenkins, Claire, PhD</creator><creator>Thomson, Nicholas R, Prof</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><general>New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><orcidid>https://orcid.org/0000-0001-9941-5799</orcidid><orcidid>https://orcid.org/0000-0002-7898-7664</orcidid></search><sort><creationdate>20150801</creationdate><title>Intercontinental dissemination of azithromycin-resistant shigellosis through sexual transmission: a cross-sectional study</title><author>Baker, Kate S, PhD ; Dallman, Timothy J, PhD ; Ashton, Philip M, PhD ; Day, Martin, BSc ; Hughes, Gwenda, PhD ; Crook, Paul D, MSc ; Gilbart, Victoria L, MSc ; Zittermann, Sandra, PhD ; Allen, Vanessa G, MD ; Howden, Benjamin P, Prof ; Tomita, Takehiro, PhD ; Valcanis, Mary, MPH ; Harris, Simon R, PhD ; Connor, Thomas R, PhD ; Sintchenko, Vitali, PhD ; Howard, Peter, BSc ; Brown, Jeremy D, MBBS ; Petty, Nicola K, PhD ; Gouali, Malika, PharmD ; Thanh, Duy Pham, MSc ; Keddy, Karen H, BSc (Med) ; Smith, Anthony M, PhD ; Talukder, Kaisar A, PhD ; Faruque, Shah M, PhD ; Parkhill, Julian, Prof ; Baker, Stephen, Prof ; Weill, François-Xavier, PhD ; Jenkins, Claire, PhD ; Thomson, Nicholas R, Prof</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c655t-292ecc93f31e0299f0b0a1aa7624ebc26d6daf3df4831cc5c9ecfe9af8ddd52c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Antibiotics</topic><topic>Azithromycin - therapeutic use</topic><topic>Bacteriology</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Criminal investigations</topic><topic>Cross-Sectional Studies</topic><topic>Disease</topic><topic>Disease Outbreaks</topic><topic>Drug Resistance, Bacterial - drug effects</topic><topic>Dysentery, Bacillary - drug therapy</topic><topic>Dysentery, Bacillary - epidemiology</topic><topic>Epidemiology</topic><topic>Evidence</topic><topic>Female</topic><topic>Genomes</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Infections</topic><topic>Infectious Disease</topic><topic>Infectious diseases</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Medical research</topic><topic>Men</topic><topic>Mens health</topic><topic>Microbiology and Parasitology</topic><topic>Middle Aged</topic><topic>Phylogeny</topic><topic>Public health</topic><topic>Risk</topic><topic>Santé publique et épidémiologie</topic><topic>Sexually transmitted diseases</topic><topic>Sexually Transmitted Diseases - drug therapy</topic><topic>Sexually Transmitted Diseases - epidemiology</topic><topic>Sexually Transmitted Diseases - microbiology</topic><topic>Shigella flexneri - drug effects</topic><topic>Shigellosis</topic><topic>STD</topic><topic>Studies</topic><topic>Travel</topic><topic>United Kingdom - epidemiology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Baker, Kate S, PhD</creatorcontrib><creatorcontrib>Dallman, Timothy J, PhD</creatorcontrib><creatorcontrib>Ashton, Philip M, PhD</creatorcontrib><creatorcontrib>Day, Martin, BSc</creatorcontrib><creatorcontrib>Hughes, Gwenda, PhD</creatorcontrib><creatorcontrib>Crook, Paul D, MSc</creatorcontrib><creatorcontrib>Gilbart, Victoria L, MSc</creatorcontrib><creatorcontrib>Zittermann, Sandra, PhD</creatorcontrib><creatorcontrib>Allen, Vanessa G, MD</creatorcontrib><creatorcontrib>Howden, Benjamin P, Prof</creatorcontrib><creatorcontrib>Tomita, Takehiro, PhD</creatorcontrib><creatorcontrib>Valcanis, Mary, MPH</creatorcontrib><creatorcontrib>Harris, Simon R, PhD</creatorcontrib><creatorcontrib>Connor, Thomas R, PhD</creatorcontrib><creatorcontrib>Sintchenko, Vitali, PhD</creatorcontrib><creatorcontrib>Howard, Peter, BSc</creatorcontrib><creatorcontrib>Brown, Jeremy D, MBBS</creatorcontrib><creatorcontrib>Petty, Nicola K, PhD</creatorcontrib><creatorcontrib>Gouali, Malika, PharmD</creatorcontrib><creatorcontrib>Thanh, Duy Pham, MSc</creatorcontrib><creatorcontrib>Keddy, Karen H, BSc (Med)</creatorcontrib><creatorcontrib>Smith, Anthony M, PhD</creatorcontrib><creatorcontrib>Talukder, Kaisar A, PhD</creatorcontrib><creatorcontrib>Faruque, Shah M, PhD</creatorcontrib><creatorcontrib>Parkhill, Julian, Prof</creatorcontrib><creatorcontrib>Baker, Stephen, Prof</creatorcontrib><creatorcontrib>Weill, François-Xavier, PhD</creatorcontrib><creatorcontrib>Jenkins, Claire, PhD</creatorcontrib><creatorcontrib>Thomson, Nicholas R, Prof</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Proquest Nursing &amp; Allied Health Source</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>The Lancet infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Baker, Kate S, PhD</au><au>Dallman, Timothy J, PhD</au><au>Ashton, Philip M, PhD</au><au>Day, Martin, BSc</au><au>Hughes, Gwenda, PhD</au><au>Crook, Paul D, MSc</au><au>Gilbart, Victoria L, MSc</au><au>Zittermann, Sandra, PhD</au><au>Allen, Vanessa G, MD</au><au>Howden, Benjamin P, Prof</au><au>Tomita, Takehiro, PhD</au><au>Valcanis, Mary, MPH</au><au>Harris, Simon R, PhD</au><au>Connor, Thomas R, PhD</au><au>Sintchenko, Vitali, PhD</au><au>Howard, Peter, BSc</au><au>Brown, Jeremy D, MBBS</au><au>Petty, Nicola K, PhD</au><au>Gouali, Malika, PharmD</au><au>Thanh, Duy Pham, MSc</au><au>Keddy, Karen H, BSc (Med)</au><au>Smith, Anthony M, PhD</au><au>Talukder, Kaisar A, PhD</au><au>Faruque, Shah M, PhD</au><au>Parkhill, Julian, Prof</au><au>Baker, Stephen, Prof</au><au>Weill, François-Xavier, PhD</au><au>Jenkins, Claire, PhD</au><au>Thomson, Nicholas R, Prof</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intercontinental dissemination of azithromycin-resistant shigellosis through sexual transmission: a cross-sectional study</atitle><jtitle>The Lancet infectious diseases</jtitle><addtitle>Lancet Infect Dis</addtitle><date>2015-08-01</date><risdate>2015</risdate><volume>15</volume><issue>8</issue><spage>913</spage><epage>921</epage><pages>913-921</pages><issn>1473-3099</issn><eissn>1474-4457</eissn><coden>LANCAO</coden><abstract>Summary Background Shigellosis is an acute, severe bacterial colitis that, in high-income countries, is typically associated with travel to high-risk regions (Africa, Asia, and Latin America). Since the 1970s, shigellosis has also been reported as a sexually transmitted infection in men who have sex with men (MSM), in whom transmission is an important component of shigellosis epidemiology in high-income nations. We aimed to use sophisticated subtyping and international sampling to determine factors driving shigellosis emergence in MSM linked to an outbreak in the UK. Methods We did a large-scale, cross-sectional genomic epidemiological study of shigellosis cases collected from 29 countries between December, 1995, and June 8, 2014. Focusing on an ongoing epidemic in the UK, we collected and whole-genome sequenced clinical isolates of Shigella flexneri serotype 3a from high-risk and low-risk regions, including cases associated with travel and sex between men. We examined relationships between geographical, demographic, and clinical patient data with the isolate antimicrobial susceptibility, genetic data, and inferred evolutionary relationships. Findings We obtained 331 clinical isolates of S flexneri serotype 3a, including 275 from low-risk regions (44 from individuals who travelled to high-risk regions), 52 from high-risk regions, and four outgroup samples (ie, closely related, but genetically distinct isolates used to determine the root of the phylogenetic tree). We identified a recently emerged lineage of S flexneri 3a that has spread intercontinentally in less than 20 years throughout regions traditionally at low risk for shigellosis via sexual transmission in MSM. The lineage had acquired multiple antimicrobial resistance determinants, and prevailing sublineages were strongly associated with resistance to the macrolide azithromycin. Eight (4%) of 206 isolates from the MSM-associated lineage were obtained from patients who had previously provided an isolate; these serial isolations indicated atypical infection patterns (eg, reinfection). Interpretation We identified transmission-facilitating behaviours and atypical course(s) of infection as precipitating factors in shigellosis-affected MSM. The intercontinental spread of antimicrobial-resistant shigella through established transmission routes emphasises the need for new approaches to tackle the public health challenge of sexually transmitted infections in MSM. Funding Wellcome Trust (grant number 098051).</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>25936611</pmid><doi>10.1016/S1473-3099(15)00002-X</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-9941-5799</orcidid><orcidid>https://orcid.org/0000-0002-7898-7664</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1473-3099
ispartof The Lancet infectious diseases, 2015-08, Vol.15 (8), p.913-921
issn 1473-3099
1474-4457
language eng
recordid cdi_hal_primary_oai_HAL_pasteur_02042957v1
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adolescent
Adult
Aged
Antibiotics
Azithromycin - therapeutic use
Bacteriology
Child
Child, Preschool
Criminal investigations
Cross-Sectional Studies
Disease
Disease Outbreaks
Drug Resistance, Bacterial - drug effects
Dysentery, Bacillary - drug therapy
Dysentery, Bacillary - epidemiology
Epidemiology
Evidence
Female
Genomes
Humans
Infant
Infant, Newborn
Infections
Infectious Disease
Infectious diseases
Life Sciences
Male
Medical research
Men
Mens health
Microbiology and Parasitology
Middle Aged
Phylogeny
Public health
Risk
Santé publique et épidémiologie
Sexually transmitted diseases
Sexually Transmitted Diseases - drug therapy
Sexually Transmitted Diseases - epidemiology
Sexually Transmitted Diseases - microbiology
Shigella flexneri - drug effects
Shigellosis
STD
Studies
Travel
United Kingdom - epidemiology
Young Adult
title Intercontinental dissemination of azithromycin-resistant shigellosis through sexual transmission: a cross-sectional study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T15%3A12%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intercontinental%20dissemination%20of%20azithromycin-resistant%20shigellosis%20through%20sexual%20transmission:%20a%20cross-sectional%20study&rft.jtitle=The%20Lancet%20infectious%20diseases&rft.au=Baker,%20Kate%20S,%20PhD&rft.date=2015-08-01&rft.volume=15&rft.issue=8&rft.spage=913&rft.epage=921&rft.pages=913-921&rft.issn=1473-3099&rft.eissn=1474-4457&rft.coden=LANCAO&rft_id=info:doi/10.1016/S1473-3099(15)00002-X&rft_dat=%3Cproquest_hal_p%3E3773071011%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1702704705&rft_id=info:pmid/25936611&rft_els_id=1_s2_0_S147330991500002X&rfr_iscdi=true